Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on October 2, 2020, regarding events occurring on September 30, 2020. The Company is incorporated in Delaware and its Class A common stock trades on the NASDAQ Capital Market under the symbol VTVT.
Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change reported is the departure of a director:
- Edward P. Taibi resigned from the Board of Directors effective September 30, 2020.
- The Company explicitly stated that Mr. Taibi did not resign due to any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's resignation.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following Mr. Taibi's resignation.
- Confirm that no other undisclosed disagreements or material events accompanied the resignation.
- Review the Company's most recent 10-Q or 10-K for actual financial performance data, as this 8-K does not include financial metrics.